Mangoceuticals (MGRX) Income from Non-Controlling Interests (2023 - 2026)
Mangoceuticals (MGRX) reported Income from Non-Controlling Interests of -$1533.0 for Q1 2026, down 1464.29% on a YoY basis from $112.37 in Q1 2025, and down 878.17% sequentially from $197.0 in Q4 2025.
Mangoceuticals (MGRX) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
Mangoceuticals (MGRX) has 4 years of Income from Non-Controlling Interests data on file, last reported at -$1533.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 1464.29% year-over-year to -$1533.0; the trailing twelve-month figure through Mar 2026 stood at -$1896.0 (down 65.88% YoY), and the FY2025 full-year result was -$461.0, up 57.35% from the prior year.
- Income from Non-Controlling Interests declined to -$1533.0 in Q1 2026, from $197.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $197.0 in Q4 2025 to a low of -$1.8 million in Q3 2023.
- A 4-year average of -$180253.5 and a median of -$292.0 in 2024 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests soared 180.74% in 2025 and plunged 1464.29% in 2026, its largest moves.
- Tracing MGRX's Income from Non-Controlling Interests over 4 years: stood at -$1.8 million in 2023, then soared by 99.99% to -$244.0 in 2024, then jumped by 180.74% to $197.0 in 2025, then slumped by 878.17% to -$1533.0 in 2026.
- Business Quant data shows MGRX's Income from Non-Controlling Interests at -$1533.0 in Q1 2026, $197.0 in Q4 2025, and -$558.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.73 Bn | 24.41 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.61 Bn | 13.71 Bn | 482.22 Mn | -157,000.00 |
| 3 | Healthequity | 8.32 Bn | 8.06 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.94 Bn | 5.63 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.80 Bn | 5.26 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.50 Bn | 4.21 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.17 Bn | 2.75 Bn | - | 646,000.00 |
| 10 | Mangoceuticals | 8.87 Mn | 8.68 Mn | 29,001.00 | -1,533.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,533.00 |
| Dec 31, 2025 | 197.00 |
| Sep 30, 2025 | -558.00 |
| Jun 30, 2025 | -2.00 |
| Mar 31, 2025 | -98.00 |
| Dec 31, 2024 | -244.00 |
| Sep 30, 2024 | -461.00 |
| Jun 30, 2024 | -340.00 |
| Mar 31, 2024 | -36.00 |
| Sep 30, 2023 | -1.80 Mn |